NCT02382367View on ClinicalTrials.gov

Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema

NACompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Pulmonary Emphysema
Interventions
OTHER

Blood sampling

Blood tests (Alpha-1 antitrypsin protein measurement, elastase-inhibitory capacity of plasma measurement, phenotypic and genotypic studies)

Trial Locations (1)

69677

Hôpital Louis Pradel - service de pneumologie, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02382367 - Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema | Biotech Hunter | Biotech Hunter